HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yutaka Kawahito Selected Research

Lipoxygenase Inhibitors

7/20055-Lipoxygenase inhibitors attenuate growth of human renal cell carcinoma and induce apoptosis through arachidonic acid pathway.
5/2004Lipoxygenase inhibitors prevent urological cancer cell growth.
11/2003Expression of lipoxygenase in human bladder carcinoma and growth inhibition by its inhibitors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yutaka Kawahito Research Topics

Disease

31Rheumatoid Arthritis
08/2022 - 01/2005
19Neoplasms (Cancer)
03/2010 - 05/2002
10Inflammation (Inflammations)
12/2021 - 01/2005
8Renal Cell Carcinoma (Grawitz Tumor)
03/2010 - 12/2003
7Arthritis (Polyarthritis)
01/2019 - 08/2004
7Prostatic Neoplasms (Prostate Cancer)
03/2010 - 05/2002
6Fibrosis (Cirrhosis)
10/2021 - 05/2007
5Testicular Neoplasms (Testicular Cancer)
03/2010 - 09/2002
5Urinary Bladder Neoplasms (Bladder Cancer)
03/2010 - 05/2003
5Urologic Neoplasms (Urological Cancer)
03/2010 - 12/2003
4Infections
02/2022 - 11/2020
4Reperfusion Injury
03/2010 - 07/2008
4Carcinogenesis
04/2009 - 07/2007
3Rheumatic Diseases (Rheumatism)
11/2020 - 11/2016
3Experimental Arthritis
01/2019 - 10/2005
3Osteoporosis
11/2016 - 01/2008
3Ischemia
07/2008 - 07/2008
3Neoplasm Metastasis (Metastasis)
01/2004 - 06/2003
3Carcinoma (Carcinomatosis)
12/2003 - 05/2003
2Surgical Wound Infection
02/2022 - 09/2015
2Pain (Aches)
01/2022 - 07/2013
2Pneumonia (Pneumonitis)
12/2021 - 01/2014
2Pulmonary Fibrosis (Fibrosing Alveolitis)
10/2021 - 01/2018
2Systemic Lupus Erythematosus (Libman-Sacks Disease)
08/2018 - 11/2014
2Connective Tissue Diseases (Connective Tissue Disease)
11/2016 - 05/2007
2Bone Resorption
11/2016 - 01/2008
2Osteoarthritis
11/2015 - 05/2008
2Lupus Nephritis
11/2014 - 01/2008
2Cachexia
10/2010 - 01/2005
2Stomach Neoplasms (Stomach Cancer)
06/2003 - 05/2002
1Adrenal Insufficiency (Adrenal Gland Hypofunction)
08/2022
1Polymyalgia Rheumatica (Rhizomelic Pseudopolyarthritis)
08/2022
1Rhinitis
07/2022
1Chronic Obstructive Pulmonary Disease (COPD)
02/2022
1Diabetes Mellitus
02/2022
1COVID-19
01/2021
1Congenital Abnormalities (Deformity)
01/2021
1Gastrointestinal Diseases (Functional Gastrointestinal Disorders)
01/2021
1Thumb deformity
01/2021
1Nutrition Disorders (Nutritional Disorders)
01/2021
1Chronic Hepatitis C
11/2020
1Oral Candidiasis (Thrush)
01/2020
1Hypoalbuminemia
01/2020
1Immune System Diseases (Immune Disorders)
01/2019
1Synovitis
09/2018
1Osteitis
09/2018

Drug/Important Bio-Agent (IBA)

13Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA
04/2009 - 11/2003
11Arachidonic Acid (Vitamin F)IBA
04/2009 - 11/2003
11Lipoxygenase (Lipoxygenase-1)IBA
04/2009 - 11/2003
8Biological ProductsIBA
02/2022 - 09/2015
7Proteins (Proteins, Gene)FDA Link
10/2021 - 03/2003
7LigandsIBA
03/2010 - 05/2002
6Antirheumatic Agents (DMARD)IBA
02/2022 - 09/2015
6Bleomycin (Blenoxane)FDA LinkGeneric
10/2021 - 05/2007
6CytokinesIBA
01/2019 - 01/2005
6Interleukin-6 (Interleukin 6)IBA
01/2019 - 03/2007
6Peroxisome Proliferator-Activated Receptors (PPAR)IBA
03/2010 - 05/2002
5Abatacept (Orencia)FDA Link
05/2019 - 08/2012
5Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2019 - 10/2005
5EicosanoidsIBA
07/2008 - 11/2003
4Pharmaceutical PreparationsIBA
07/2022 - 01/2005
4leukotriene D4 receptor (cysteinyl leukotriene receptor)IBA
03/2010 - 07/2007
4PPAR gammaIBA
12/2003 - 05/2002
3GlucocorticoidsIBA
08/2022 - 01/2016
3CollagenIBA
01/2019 - 05/2007
3Prednisolone (Predate)FDA LinkGeneric
11/2016 - 07/2007
3Small Interfering RNA (siRNA)IBA
11/2015 - 10/2005
3Telmisartan (Micardis)FDA Link
03/2010 - 08/2008
3Lipoxygenase InhibitorsIBA
07/2005 - 11/2003
2Therapeutic UsesIBA
10/2021 - 11/2015
2Sphingosine-1-Phosphate ReceptorsIBA
01/2019 - 01/2014
2indium-bleomycinIBA
01/2018 - 01/2014
2Diphosphonates (Bisphosphonates)IBA
11/2016 - 01/2016
2Infliximab (Remicade)FDA Link
06/2016 - 06/2007
2Interleukin-10 (Interleukin 10)IBA
01/2015 - 01/2014
2MucinsIBA
03/2011 - 03/2003
2sphingosine 1-phosphate (sphingosine-1-phosphate)IBA
02/2008 - 03/2006
2ProstaglandinsIBA
01/2008 - 03/2003
2mizoribineIBA
01/2008 - 07/2007
2Adrenal Cortex Hormones (Corticosteroids)IBA
07/2007 - 12/2004
2Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA
06/2004 - 04/2003
2Cyclooxygenase 2 (Cyclooxygenase-2)IBA
02/2004 - 03/2003
2Arachidonate 12-Lipoxygenase (12 Lipoxygenase)IBA
01/2004 - 11/2003
2PPAR alphaIBA
05/2003 - 09/2002
1Biosimilar PharmaceuticalsIBA
01/2022
1titanium dioxide (Titania)FDA Link
12/2021
1C-Reactive ProteinIBA
01/2021
1Particulate MatterIBA
01/2021
1Tacrolimus (Prograf)FDA LinkGeneric
01/2021
1Air Pollutants (Pollutants, Air)IBA
01/2021
1InterferonsIBA
11/2020
1Antiviral Agents (Antivirals)IBA
11/2020
1Serum AlbuminIBA
01/2020
1AntibodiesIBA
01/2019

Therapy/Procedure

11Therapeutics
02/2022 - 06/2004
2Orthopedic Procedures
02/2022 - 09/2015
1Operative Time
02/2022
1Exercise Therapy (Therapy, Exercise)
01/2022
1Replacement Arthroplasty
01/2022
1Drug Therapy (Chemotherapy)
01/2021